Paper
19 February 2009 Energy transfer-based biosensing of protease activity measured using an electroluminescent platform
Author Affiliations +
Abstract
We present a biosensing platform that uses spatial electroluminescent (EL) illumination combined with charge-coupled device (CCD)-based detection for fluorescence measurements. The resulting EL-CCD detector platform was used to monitor different protease activities with substrates labeled for fluorescence resonance energy transfer (FRET)-based assays. The first uses a commercial FITC/DABCYL-SNAP-25 peptide substrate to monitor the activity of the light chain derivative (LcA) of botulinum neurotoxin A, achieving a limit of detection (LOD) of 1.25 nM (62 ng/ml). The second protease activity assay measured trypsin proteolysis using peptide substrates immobilized onto semiconductor quantum dot (QD) nanoparticles with a LOD of 6.2 nM trypsin (140 ng/ml). The specific ovomucoid inhibition of trypsin activity was also monitored. The highlighted studies clearly demonstrate the utility of the EL-CCD detector platform for monitoring fluorescent-based protease activity assays with potential healthcare applications, including point-of-care diagnostics.
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kim E. Sapsford, Steven Sun, Jesse Francis, Yordan Kostov, Avraham Rasooly, Dorothy Farrell, Hedi Mattoussi, and Igor L. Medintz "Energy transfer-based biosensing of protease activity measured using an electroluminescent platform", Proc. SPIE 7167, Frontiers in Pathogen Detection: From Nanosensors to Systems, 71670X (19 February 2009); https://doi.org/10.1117/12.809301
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Fluorescence resonance energy transfer

Sensors

Luminescence

Biosensing

Charge-coupled devices

Electroluminescence

Quantum dots

Back to Top